Profile picture
Scott Gottlieb, M.D. @SGottliebFDA
, 3 tweets, 2 min read Read on Twitter
THREAD: Thank you to the #ODAC for their robust discussion yesterday and engagement in the science that goes into developing and reviewing biosimilars.
#FDA is working to advance the science and policies to make the development of biosimilars more efficient, to increase the acceptance of biosimilars, and to avoid the regulatory gaming that can deter competition.
Biologics have become a crucial tool in treating many serious and life-threatening diseases, including cancer. But their costs may be prohibitively high for some patients. #FDA is taking new steps to facilitate more competition from biosimilars to drive competition and access
Missing some Tweet in this thread?
You can try to force a refresh.

Like this thread? Get email updates or save it to PDF!

Subscribe to Scott Gottlieb, M.D.
Profile picture

Get real-time email alerts when new unrolls are available from this author!

This content may be removed anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just three indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member and get exclusive features!

Premium member ($30.00/year)

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!